Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIC263029 in BKV Infection in Kidney Transplant Recipients
NCT07503561Phase 2Recruiting
- Sponsor
- AiCuris
- Start
- Oct 2026
- Primary completion
- Sep 2027
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of AIC263029 in BK virus infection, sponsored by AiCuris. Started Oct 2026; status: recruiting.
02
Drugs
AIC263029
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT07503561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503561.